Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes

European Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2008, Pages 381-385

  Djordjevic, Natasa ^a,b   Ghotbi, Roza ^a   Bertilsson, Leif ^a   Jankovic, Slobodan ^b   Aklillu, Eleni ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Caffeine; Coffee; CYP1A2; Ethnicity; Phenotype

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2; ORAL CONTRACEPTIVE AGENT; PARAXANTHINE;

ADULT; ARTICLE; COFFEE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SERBIA; SEX DIFFERENCE; SMOKING HABIT; SWEDEN;

ADOLESCENT; ADULT; COFFEE; CYTOCHROME P-450 CYP1A2; ENZYME INDUCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; SMOKING; SWEDEN; YUGOSLAVIA;

EID: 40049099671     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0438-6     Document Type: Article

References (27)

1. Ma X, Idle JR, Krausz KW, Gonzalez FJ (2005) Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos 33(4):489-494
2. Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5(5):259-274
3. Bertilsson L, Dahl M, Ingelman-Sundberg M, Johansson I, Sjöqvist F (1995) Inter-individual and inter-ethnic differences in polymorphic drug oxydation. In: Pacifici G, Fracchia G (eds) Advances in drug metabolism in man. European Commission, Bruxelles, pp 86-136
4. Tassaneeyakul W, Birkett DJ, McManus ME, Tassaneeyakul W, Veronese ME, Andersson T, Tukey RH, Miners JO (1994) Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol 47(10):1767-1776
5. Carrillo JA, Christensen M, Ramos SI, Alm C, Dahl ML, Benitez J, Bertilsson L (2000) Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 22(4):409-417
6. Aklillu E, Carrillo JA, Makonnen E, Hellman K, Pitarque M, Bertilsson L, Ingelman-Sundberg M (2003) Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol 64(3):659-669
7. Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, Knize MG, Greenberg A, Watkins PB (1999) Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117(1):89-98
8. Zhou H, Josephy PD, Kim D, Guengerich FP (2004) Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch Biochem Biophys 422(1):23-30
9. Kalow W, Tang BK (1991) Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 49(1):44-48
10. Han XM, Ouyang DS, Chen XP, Shu Y, Jiang CH, Tan ZR, Zhou HH (2002) Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br J Clin Pharmacol 54(5):540-543
11. Parker AC, Pritchard P, Preston T, Choonara I (1998) Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol 45(2):176-178
12. Rasmussen BB, Maenpaa J, Pelkonen O, Loft S, Poulsen HE, Lykkesfeldt J, Brosen K (1995) Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. Br J Clin Pharmacol 39(2):151-159
13. Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L (2007) Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol 63(6):537-546
14. Kalow W, Tang BK (1991) Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 50(5 Pt 1):508-519
15. Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U (1999) Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9(2):131-144
16. Relling MV, Lin JS, Ayers GD, Evans WE (1992) Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 52(6):643-658
17. Masimirembwa CM, Beke M, Hasler JA, Tang BK, Kalow W (1995) Low CYP1A2 activity in rural Shona children of Zimbabwe. Clin Pharmacol Ther 57(1):25-31
18. Okey AB (1990) Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45(2):241-298
19. Ayalogu EO, Snelling J, Lewis DF, Talwar S, Clifford MN, Ioannides C (1995) Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta 1272(2):89-94
20. Horn EP, Tucker MA, Lambert G, Silverman D, Zametkin D, Sinha R, Hartge T, Landi MT, Caporaso NE (1995) A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer. Cancer Epidemiol Biomarkers Prev 4(5):529-533
21. Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P (1996) Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 5(9):693-698
22. Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV (1997) Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7(1):11-19
23. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1991) Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Monogr Eval Carcinog Risks Hum 51:1-513
24. Albertini S, Friederich U, Schlatter C, Wurgler FE (1985) The influence of roasting procedure on the formation of mutagenic compounds in coffee. Food Chem Toxicol 23(6):593-597
25. Del Bubba M, Zanieri L, Galvan P, Donzelli GP, Checchini L, Lepri L (2005) Determination of polycyclic aromatic hydrocarbons (PAHs) and total fats in human milk. Ann Chim 95(9-10):629-641
26. Houessou JK, Benac C, Delteil C, Camel V (2005) Determination of polycyclic aromatic hydrocarbons in coffee brew using solid-phase extraction. J Agric Food Chem 53(4):871-879
27. Chen ML (2006) Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 45(10):957-964